Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)

ClinicalTrials.gov ID: NCT00543400

Public ClinicalTrials.gov record NCT00543400. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 11:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective is to evaluate the safety and feasibility of using M118 as an anticoagulant in the target population of subjects with stable coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). The secondary objectives are to evaluate the effect of M118 on procedural indices including procedure success, abrupt closure, post-procedure TIMI flow, and catheter thrombus. Substudy Primary Objective The primary objective of the substudy is to characterize the pharmacokinetic and pharmacodynamic profile of M118 among subjects with stable coronary artery disease undergoing elective PCI.

Study identification

NCT ID
NCT00543400
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Momenta Pharmaceuticals, Inc.
Industry
Enrollment
503 participants

Conditions and interventions

Eligibility (public fields only)

Age range
19 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2007
Primary completion
Mar 31, 2009
Completion
Apr 30, 2009
Last update posted
Oct 14, 2019

2007 – 2009

United States locations

U.S. sites
37
U.S. states
19
U.S. cities
36
Facility City State ZIP Site status
Central Arkansas Veterans Healthcare System Little Rock Arkansas 72205
Washington Hospital Center, Medstar Research Institute Washington D.C. District of Columbia 20010
Jim Moran Heart & Vascular Research Institute Fort Lauderdale Florida 33308
Shands Jacksonville Medical Center (UFL) Jacksonville Florida 32209
Cardiology Research Associates Ormond Beach Florida 32174
Suncoast Cardiovascular Research St. Petersburg Florida 33701
Emory University Hospital Atlanta Georgia 30322
Advocate Good Shephard Hospital Barrington Illinois 60010
Rush University Medical Center Chicago Illinois 60612
University of Chicago Chicago Illinois 60637
Trinity Medical Center Rock Island Illinois 61201
Midwest Cardiovascular Research Foundation Davenport Iowa 52803
University of Kentucky-Gill Heart Institute Lexington Kentucky 40536
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
University of Michigan Health System Ann Arbor Michigan 48109-5869
Henry Ford Hospital Heart & Vascular Institute Detroit Michigan 48202
Genesys Regional Medical Center Grand Blanc Michigan 48439
Saint Mary's Duluth Clinic Health Center Duluth Minnesota 55805
Minneapolis VA Medical Center Minneapolis Minnesota 55417
Saint-Luke's Hospital / Mid America Heart Institute Kansas City Missouri 64111
Saint Louis University Hospital St Louis Missouri 63110
UNC Health Systems Chapel Hill North Carolina 27514
Wake Forest University Health Sciences Winston-Salem North Carolina 27157-1045
Riverside Methodist Hospital Columbus Ohio 43214
Genesis Health Care System Zanesville Ohio 43701
Allegheny Hospital Pittsburgh Pennsylvania 15212
Black Hills Clinical Research Center Rapid City South Dakota 57701
Centennial Heart Cardiovascular Consultants Nashville Tennessee 37203
Northwest Texas Healthcare System_Amarillo Heart Clinical Research Institute, Inc. Amarillo Texas 79106
Austin Heart, P.A. Austin Texas 78756
Plaza Medical Center of Fort Worth Fort Worth Texas 76104
The Methodist Hospital Houston Texas 77030
Victoria Heart & Vascular Center Victoria Texas 77901
Providence Health Center Waco Texas 76712
UVA Cardiology, UVA Health System Charlottesville Virginia 22908
McGuire VA Medical Center Richmond Virginia 23249
Comprehensive Cardiology Care Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00543400, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 14, 2019 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00543400 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →